Other: Pharmacogenomic Study ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 26 | HTLV-1関連脊髄症 | 1 |
26. HTLV-1関連脊髄症
臨床試験数 : 28 / 薬物数 : 48 - (DrugBank : 28) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 127
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02631746 (ClinicalTrials.gov) | February 21, 2017 | 15/12/2015 | Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma | Phase II Trial of Nivolumab for HTLV-Associated Adult T Cell Leukemia/Lymphoma | Acute Adult T-Cell Leukemia/Lymphoma;Adult T-Cell Leukemia/Lymphoma;Chronic Adult T-Cell Leukemia/Lymphoma;HTLV-1 Infection;Lymphomatous Adult T-Cell Leukemia/Lymphoma;Smoldering Adult T-Cell Leukemia/Lymphoma | Other: Laboratory Biomarker Analysis;Biological: Nivolumab;Other: Pharmacogenomic Study | National Cancer Institute (NCI) | NULL | Completed | 18 Years | N/A | All | 3 | Phase 2 | United States |